Showing results (121-130 of 288) with videos related to
Sort By:
Pageof 29
Circulation|October 15, 2008
Long-term clinical outcomes after drug-eluting and bare-metal stenting in MassachusettsLaura Mauri, Treacy S Silbaugh, Robert E Wolf, et al.Circulation|January 24, 2008
Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patientsAlanna Coolong, Donald S Baim, Richard E Kuntz, et al.Journal of Neurochemistry|February 19, 2019
GM1 promotes TrkA-mediated neuroblastoma cell differentiation by occupying a plasma membrane domain different from TrkAElena Chiricozzi, Erika Di Biase, Margherita Maggioni, et al.Journal of Lipid Research|November 25, 2014
Direct interaction, instrumental for signaling processes, between LacCer and Lyn in the lipid rafts of neutrophil-like cellsElena Chiricozzi, Maria Grazia Ciampa, Giuseppina Brasile, et al.American Heart Journal|January 28, 2019
Design and rationale of a randomized noninferiority trial to evaluate the SurVeil drug-coated balloon in subjects with stenotic lesions of the femoropopliteal artery - the TRANSCEND studySammy Elmariah, Gary M Ansel, Marianne Brodmann, et al.The Journal of Biological Chemistry|March 10, 2017
Altered expression of ganglioside GM3 molecular species and a potential regulatory role during myoblast differentiationShinji Go, Shiori Go, Lucas Veillon, et al.International Journal of Molecular Sciences|March 29, 2023
Combined Inhibition of Hedgehog and HDAC6: In Vitro and In Vivo Studies Reveal a New Role for Lysosomal Stress in Reducing Glioblastoma Cell ViabilityAlex Pezzotta, Loredana Brioschi, Sabrina Carbone, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 17, 2007
Carotid artery stenting with emboli protection surveillance study: thirty-day results of the CASES-PMS studyBarry T Katzen, Frank J Criado, Stephen R Ramee, et al.The American Journal of Cardiology|August 30, 2016
Frequency of Stent Thrombosis Risk at 5 Years in Women Versus Men With Zotarolimus-Eluting Compared With Sirolimus-Eluting StentMonique Ten Haaf, Yolande Appelman, William Wijns, et al.JACC. Cardiovascular Interventions|February 5, 2010
Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)Eric L Eisenstein, Martin B Leon, David E Kandzari, et al.Pageof 29